HIGH-DOSE METHOTREXATE - A CLINICAL AND PHARMACOKINETIC EVALUATION - TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK USING A PROSPECTIVE MATHEMATICAL-MODEL AND PHARMACOKINETIC SURVEILLANCE

被引：23

作者：

FAVRE, R

MONJANEL, S

ALFONSI, M

PRADOURA, JP

BAGARRYLIEGEY, D

CLEMENT, S

IMBERT, AM

LENA, N

DISTRIA, JC

CANO, JP

CARCASSONNE, Y

机构：

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 9卷 / 03期

关键词：

D O I：

10.1007/BF00257744

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：156 / 160

页数：5

共 12 条

[1]

BARTELS H, 1971, CLIN CHIM ACTA, V32, P81, DOI 10.1016/0009-8981(71)90467-0

[2]

BERTINO J R, 1964, Methods Med Res, V10, P297

[3]

EVANS WE, 1979, CANCER CHEMOTH PHARM, V3, P161

[4]

FISCHER RA, 1924, P INT MATH C TORONTO, V2, P805

[5]

GOH TS, 1979, CANCER CHEMOTH PHARM, V3, P177

[6] THE ROLE OF 7-HYDROXYMETHOTREXATE DURING METHOTREXATE ANTI-CANCER THERAPY [J].

LANKELMA, J ;

VANDERKLEIN, E ;

RAMAEKERS, F .

CANCER LETTERS, 1980, 9 (02) :133-142

[7]

MONJANEL S, 1979, CANCER CHEMOTH PHARM, V3, P189

[8]

MYRS RG, 1975, CANCER CHEM REP, V6, P19

[9]

PINEDO HM, 1977, CANCER TREAT REP, V61, P709

[10]

Schwartz D., 1963, METHODES STATISTIQUE, P67

← 1 2 →